{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:58Z","timestamp":1790803318752,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"DOI":"10.1007\/s11883-026-01424-0","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:29Z","timestamp":1778919509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5145-8626","authenticated-orcid":false,"given":"Ali Bin","family":"Abdul Jabbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unaiza","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalsoom","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Inam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnoor","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mannan Khan","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","unstructured":"Abdul Jabbar AB, Naeem U, Zulfiqar K, Ahmed S, Hinkamp C, Inam M et al. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference. Curr Atheroscler Rep. 2025;27(1):107. https:\/\/doi.org\/10.1007\/s11883-025-01355-2 PubMed PMID: 41145911.","DOI":"10.1007\/s11883-025-01355-2"},{"issue":"1","key":"1424_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11883-025-01376-x","volume":"28","author":"AB Abdul Jabbar","year":"2026","unstructured":"Abdul Jabbar AB, Naeem U, Zulfiqar K, Ahmed S, Inam M, Hinkamp C, et al. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2026;28(1):7. https:\/\/doi.org\/10.1007\/s11883-025-01376-x . PubMed PMID: 41493497.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/j.jacl.2024.01","volume":"18","author":"R Puri","year":"2024","unstructured":"Puri R, Bansal M, Mehta V, Duell PB, Wong ND, Iyengar SS, et al. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV. J Clin Lipidol. 2024;18(3):e351\u201373. https:\/\/doi.org\/10.1016\/j.jacl.2024.01. .006 PubMed PMID: 38485619.","journal-title":"J Clin Lipidol"},{"issue":"18","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017;376(18):1713\u201322. 10. 1056\/NEJMoa1615664 PubMed PMID: 28304224.","journal-title":"N Engl J Med"},{"issue":"22","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018;379(22):2097\u2013107. 10. 1056\/NEJMoa1801174 PubMed PMID: 30403574.","journal-title":"N Engl J Med"},{"issue":"2","key":"1424_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2514428","volume":"394","author":"EA Bohula","year":"2026","unstructured":"Bohula EA, Marston NA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, et al. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke. N Engl J Med. 2026;394(2):117\u201327. doi:10.1056\/NEJMoa2514428 PubMed PMID: 41211925.","journal-title":"N Engl J Med"},{"key":"1424_CR7","doi-asserted-by":"publisher","unstructured":"Marston NA, Bohula EA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, et al. Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial. JAMA. 2026 Mar;28. https:\/\/doi.org\/10.1001\/jama.2026.3277.","DOI":"10.1001\/jama.2026.3277"},{"issue":"11","key":"1424_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa","volume":"28","author":"KK Ray","year":"2021","unstructured":"Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, et al. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol. 2021;28(11):1279\u201389. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa. 047 PubMed PMID: 33580789.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"1424_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jama.2025.20620","volume":"335","author":"CM Ballantyne","year":"2026","unstructured":"Ballantyne CM, Gellis L, Tardif JC, Banka P, Navar AM, Asprusten EA, et al. Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial. JAMA. 2026;335(2):129\u201339. https:\/\/doi.org\/10.1001\/jama.2025.20620 . PubMed PMID: 41206969; PubMed Central PMCID: PMC12598580.","journal-title":"JAMA"},{"issue":"6","key":"1424_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa2511002","volume":"394","author":"AM Navar","year":"2026","unstructured":"Navar AM, Mikhailova E, Catapano AL, Banka P, Blom DJ, Cadena A, et al. A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide. N Engl J Med. 2026;394(6):529\u201339. https:\/\/doi.org\/10.1056\/NEJMoa2511002.","journal-title":"N Engl J Med"},{"key":"1424_CR11","doi-asserted-by":"publisher","unstructured":"Saeed A, Kinoush S, Virani SS, Lipoprotein (a), editors. Recent Updates on a Unique Lipoprotein. Curr Atheroscler Rep. 2021;23(8):41. https:\/\/doi.org\/10.1007\/s11883-021-00940-5 PubMed PMID: 34146181; PubMed Central PMCID: PMC8214056.","DOI":"10.1007\/s11883-021-00940-5"},{"key":"1424_CR12","doi-asserted-by":"publisher","unstructured":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia. A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation [Internet]. [cited 2026 Apr 20]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000001423","DOI":"10.1161\/CIR.0000000000001423"},{"issue":"1","key":"1424_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-050124-025051","volume":"77","author":"ML Koschinsky","year":"2026","unstructured":"Koschinsky ML, Kalra DK, Boffa MB. Lipoprotein(a): An Underappreciated Inherited Risk Factor for Atherosclerosis, Aortic Stenosis, and Abdominal Aortic Aneurysm. Annu Rev Med. 2026;77(1):31\u201343. https:\/\/doi.org\/10.1146\/annurev-med-050124-025051 . PubMed PMID: 41232565.","journal-title":"Annu Rev Med"},{"key":"1424_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a. Lancet. 2024;403(10440):2100\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(. 24)00367-2 PubMed PMID: 38582094; PubMed Central PMCID: PMC11126520. systematic analysis for the Global Burden of Disease Study 2021."},{"key":"1424_CR15","doi-asserted-by":"publisher","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al. 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/doi.org\/10.1093\/eurheartj\/ehae177","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"1424_CR16","doi-asserted-by":"publisher","unstructured":"Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, AHA\/ACC\/ASE\/CHEST et al. \/SAEM\/SCCT\/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368\u2013454. https:\/\/doi.org\/10.1161\/CIR.0000000000001029","DOI":"10.1161\/CIR.0000000000001029"},{"issue":"21","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.jacc.2022.08.805","volume":"80","author":"S Winther","year":"2022","unstructured":"Winther S, Schmidt SE, Foldyna B, Mayrhofer T, Rasmussen LD, Dahl JN, et al. Coronary Calcium Scoring Improves Risk Prediction in Patients With Suspected Obstructive Coronary Artery Disease. JACC. 2022;80(21):1965\u201377. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.805.","journal-title":"JACC"},{"issue":"21","key":"1424_CR18","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.jacc.2020.09.585","volume":"76","author":"S Winther","year":"2020","unstructured":"Winther S, Schmidt SE, Mayrhofer T, B\u00f8tker HE, Hoffmann U, Douglas PS, et al. Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease. JACC. 2020;76(21):2421\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.585.","journal-title":"JACC"},{"key":"1424_CR19","doi-asserted-by":"publisher","unstructured":"Design and Rationale of GPS-CAD. Global Pretest Probability Study of Coronary Artery Disease | JACC: Asia [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacasi.2025.11.016","DOI":"10.1016\/j.jacasi.2025.11.016"},{"issue":"7","key":"1424_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11883-020-00846-8","volume":"22","author":"A Hussain","year":"2020","unstructured":"Hussain A, Ballantyne CM, Saeed A, Virani SS, Triglycerides, Risk Reduction ASCVD. Recent Insights and Future Directions. Curr Atheroscler Rep. 2020;22(7):25. https:\/\/doi.org\/10.1007\/s11883-020-00846-8 . PubMed PMID: 32494924.","journal-title":"Curr Atheroscler Rep"},{"issue":"13","key":"1424_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa2507227","volume":"393","author":"BA Bergmark","year":"2025","unstructured":"Bergmark BA, Marston NA, Prohaska TA, Alexander VJ, Zimerman A, Moura FA, et al. Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. N Engl J Med. 2025;393(13):1279\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2507227.","journal-title":"N Engl J Med"},{"key":"1424_CR22","doi-asserted-by":"publisher","unstructured":"Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis. Essence\u2013TIMI 73b Imaging Study | Circulation [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.126.080012","DOI":"10.1161\/CIRCULATIONAHA.126.080012"},{"key":"1424_CR23","doi-asserted-by":"publisher","unstructured":"Juraschek SP, Col H, Ferro K, Turkson-Ocran RAN, Cluett JL, Davis RB, et al. DASH-patterned groceries and effects on blood pressure in adults treated for hypertension: the GoFreshRx randomized trial. Nat Med. 2026;1\u20139. https:\/\/doi.org\/10.1038\/s41591-026-04319-4.","DOI":"10.1038\/s41591-026-04319-4"},{"issue":"1","key":"1424_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2025.21112","volume":"335","author":"SP Juraschek","year":"2026","unstructured":"Juraschek SP, Col H, Ferro K, Turkson-Ocran RAN, Cluett JL, Davis RB, et al. DASH-Patterned Groceries and Effects on Blood Pressure: The GoFresh Randomized Clinical Trial. JAMA. 2026;335(1):36\u201348. https:\/\/doi.org\/10.1001\/jama.2025.21112.","journal-title":"JAMA"},{"issue":"1","key":"1424_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11886-022-01826-x","volume":"25","author":"AA Abrahamowicz","year":"2023","unstructured":"Abrahamowicz AA, Ebinger J, Whelton SP, Commodore-Mensah Y, Yang E. Racial and Ethnic Disparities in Hypertension: Barriers and Opportunities to Improve Blood Pressure Control. Curr Cardiol Rep. 2023;25(1):17\u201327. https:\/\/doi.org\/10.1007\/s11886-022-01826-x . PubMed PMID: 36622491; PubMed Central PMCID: PMC9838393.","journal-title":"Curr Cardiol Rep"},{"issue":"9","key":"1424_CR26","doi-asserted-by":"publisher","first-page":"e003532","DOI":"10.1161\/CIRCOUTCOMES.116.003532","volume":"10","author":"HM Kelli","year":"2017","unstructured":"Kelli HM, Hammadah M, Ahmed H, Ko YA, Topel M, Samman-Tahhan A, et al. Association Between Living in Food Deserts and Cardiovascular Risk. Circ Cardiovasc Qual Outcomes. 2017;10(9):e003532. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.003532 . PubMed PMID: 28904075; PubMed Central PMCID: PMC5810926.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"18","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/CIR.0000000000001182","volume":"148","author":"KG Volpp","year":"2023","unstructured":"Volpp KG, Berkowitz SA, Sharma SV, Anderson CAM, Brewer LC, Elkind MSV, et al. Food Is Medicine: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(18):1417\u201339. https:\/\/doi.org\/10.1161\/CIR.0000000000001182 . PubMed PMID: 37767686; PubMed Central PMCID: PMC12168720.","journal-title":"Circulation"},{"issue":"24","key":"1424_CR28","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1056\/NEJMoa2505928","volume":"393","author":"SJ Nicholls","year":"2025","unstructured":"Nicholls SJ, Pavo I, Bhatt DL, Buse JB, Prato SD, Kahn SE, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. N Engl J Med. 2025;393(24):2409\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2505928.","journal-title":"N Engl J Med"},{"key":"1424_CR29","doi-asserted-by":"publisher","unstructured":"Nissen SE, Wolski K, D\u2019Alessio D, Weerakkody G, Kiljanski J, Wiese RJ, et al. Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial. JAMA Cardiol. 2026 Mar;28. https:\/\/doi.org\/10.1001\/jamacardio.2026.0767.","DOI":"10.1001\/jamacardio.2026.0767"},{"issue":"3","key":"1424_CR30","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.jacadv.2024.101582","volume":"4","author":"P Cataldo Miranda","year":"2025","unstructured":"Cataldo Miranda P, Gasevic D, Trin C, Stub D, Zoungas S, Kaye DM, et al. Beta-Blocker Therapy After Myocardial Infarction. JACC Adv. 2025;4(3):101582. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101582 . PubMed PMID: 39889325; PubMed Central PMCID: PMC11834082.","journal-title":"JACC Adv"},{"key":"1424_CR31","doi-asserted-by":"publisher","unstructured":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure. A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation [Internet]. [cited 2026 Apr 4]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000001063","DOI":"10.1161\/CIR.0000000000001063"},{"issue":"15","key":"1424_CR32","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","volume":"390","author":"T Yndigegn","year":"2024","unstructured":"Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, et al. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. N Engl J Med. 2024;390(15):1372\u201381. https:\/\/doi.org\/10.1056\/NEJMoa2401479.","journal-title":"N Engl J Med"},{"issue":"19","key":"1424_CR33","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","volume":"393","author":"B Ibanez","year":"2025","unstructured":"Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fern\u00e1ndez-Vazquez F, Pelizzoni V, et al. Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction. N Engl J Med. 2025;393(19):1889\u2013900. https:\/\/doi.org\/10.1056\/NEJMoa2504735.","journal-title":"N Engl J Med"},{"issue":"9","key":"1424_CR34","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9\u2013119. 10. 1161\/CIR.0000000000001168 PubMed PMID: 37471501.","journal-title":"Circulation"},{"issue":"13","key":"1424_CR35","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMoa2601005","volume":"394","author":"KH Choi","year":"2026","unstructured":"Choi KH, Kang D, Kim W, Doh JH, Kim J, Park YH, et al. Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. N Engl J Med. 2026;394(13):1302\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2601005.","journal-title":"N Engl J Med"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-026-01424-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:30Z","timestamp":1778919510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-026-01424-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s11883-026-01424-0","relation":{"references":[{"id-type":"doi","id":"10.1016\/S0140-6736(","asserted-by":"subject"}]},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declaration"}},{"value":"SSV has received research funding from the National Institutes of Health, the US Department of Veterans Affairs, the NIHR UK, the Tahir and Jooma Family, and the Asharia Family. Dr. Slipczuk reports grants from Amgen, grants from Philips, personal fees from Elsevier, and others from APQ Health Inc during the conduct of the study.Dr. Slipczuk reports grants from Amgen, grants from Philips, personal fees from Elsevier, and others from APQ Health Inc during the conduct of the study.ABAJ has nothing to disclose.UN has nothing to disclose.KZ has nothing to disclose.SA has nothing to disclose.MI has nothing to disclose.AH has nothing to disclose.AMKM has nothing to disclose.CK has nothing to disclose.AS has nothing to disclose.DKK has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animal or human subjects were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"SSV has received research funding from the National Institutes of Health, the US Department of Veterans Affairs, the NIHR UK, the Tahir and Jooma Family, and the Asharia Family.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"49"}}